Hallucination induced by paroxetine discontinuation in patients with major depressive disorders

Psychiatry and Clinical Neurosciences

Volumn 65, Issue 4, 2011, Pages 384-385

  Yasui Furukori, Norio ^a   Kaneko, Sunao ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

discontinuation syndrome; hallucination; paroxetine

Indexed keywords

PAROXETINE;

ADULT; ANXIETY; ANXIETY DISORDER; APPETITE DISORDER; ARTICLE; AUDITORY HALLUCINATION; CASE REPORT; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG INDUCED HEADACHE; FATIGUE; FEMALE; HEADACHE; HUMAN; INSOMNIA; LASSITUDE; LONELINESS; MAJOR DEPRESSION; NAUSEA; NIGHTMARE; PATIENT COMPLIANCE; SUICIDAL IDEATION; THORAX PAIN; VISUAL HALLUCINATION; WITHDRAWAL SYNDROME;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER, MAJOR; DIZZINESS; FEMALE; HALLUCINATIONS; HEADACHE; HUMANS; NAUSEA; PAROXETINE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 79959651655     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2011.02211.x     Document Type: Article

References (9)

1. Lejoyeux M, Ades J,. Antidepressant discontinuation: a review of the literature. J. Clin. Psychiatry 1997; 58 (Suppl. 7): 11-16. (Pubitemid 27305034)
2. Schatzberg AF, Haddad P, Kaplan EM, et al,. Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel. J. Clin. Psychiatry 1997; 58 (Suppl. 7): 5-10. (Pubitemid 27305033)
3. Lader M,. Pharmacotherapy of mood disorders and treatment discontinuation. Drugs 2007; 67: 1657-1663. (Pubitemid 47263175)
4. Price JS, Waller PC, Wood SM, MacKay AV,. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal. Br. J. Clin. Pharmacol. 1996; 42: 757-763. (Pubitemid 26417618)
5. Rosenbaum JF, Fava M, Hoog SL, Ascroft RC, Krebs WB,. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol. Psychiatry 1998; 44: 77-87. (Pubitemid 28305526)
6. Hindmarch I, Kimber S, Cockle SM,. Abrupt and brief discontinuation of antidepressant treatment: effects on cognitive function and psychomotor performance. Int. Clin. Psychopharmacol. 2000; 15: 305-318.
7. Hayakawa Y, Sekine A, Shimizu T,. Delirium induced by abrupt discontinuation of paroxetine. J. Neuropsychiatry Clin. Neurosci. 2004; 16: 119-120. (Pubitemid 38233374)
8. Blum D, Maldonado J, Meyer E, Lansberg M,. Delirium following abrupt discontinuation of fluoxetine. Clin. Neurol. Neurosurg. 2008; 110: 69-70. (Pubitemid 350266172)
9. Schatzberg AF, Haddad P, Kaplan EM, et al,. Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel. J. Clin. Psychiatry 1997; 58 (Suppl. 7): 23-27. (Pubitemid 27305036)